Lilly’s ambitious diabetes drug Mounjaro fails to impress in the fourth quarter
February 02, 2023 at 13:49 PM EST
The new Type 2 diabetes treatment may be in high demand, but sales came in far below Wall Street’s expectations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following